Nutritional changes in patients with locally advanced head and neck cancer during treatment

被引:52
|
作者
Arribas, L. [1 ,2 ,3 ,4 ]
Hurtos, L. [1 ,2 ]
Taberna, M. [2 ,3 ,4 ,5 ,6 ]
Peiro, I. [1 ,2 ]
Vilajosana, E. [3 ]
Lozano, A. [2 ,3 ,7 ]
Vazquez, S. [2 ,3 ,5 ]
Mesia, R. [2 ,3 ,4 ,8 ]
Virgili, N. [2 ,4 ,9 ]
机构
[1] Catalan Inst Oncol ICO, Clin Nutr Unit, Barcelona, Spain
[2] Bellvitge Biomed Res Inst IDIBELL, Barcelona, Spain
[3] Bellvitge Univ Hosp, Catalan Inst Oncol ICO, Head & Neck Canc Unit, Barcelona, Spain
[4] Univ Barcelona, Barcelona, Spain
[5] Catalan Inst Oncol ICO, Med Oncol Dept, Barcelona, Spain
[6] Catalan Inst Oncol ICO, Canc Epidemiol Res Program, Barcelona, Spain
[7] Catalan Inst Oncol ICO, Radiat Oncol Dept, Barcelona, Spain
[8] Catalan Inst Oncol ICO, Med Oncol Dept, Barcelona, Spain
[9] Bellvitge Univ Hosp, Nutr & Endocrinol Dept, Nutr & Dietet Unit, Barcelona, Spain
关键词
Clinical Oncology treatment; Head and neck cancer; Nutrition; Dietary counseling; Fat free mass; SQUAMOUS-CELL CARCINOMA; BIOELECTRICAL-IMPEDANCE ANALYSIS; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; ASSESSMENT PG-SGA; BODY-COMPOSITION; CHEMOTHERAPY; CHEMORADIOTHERAPY; CETUXIMAB; CACHEXIA; THERAPY;
D O I
10.1016/j.oraloncology.2017.06.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The purpose of the study is to evaluate changes in body composition and nutritional status that occur throughout the oncological treatment in head and neck cancer patients. Methods: A prospective cohort observational study in patients diagnosed with head and neck squamous cell carcinoma (HNSCC) that underwent treatment with induction chemotherapy (iCT) followed by chemoradiotherapy or bioradiotherapy were invited to participate. All patients had dietetic counseling from the diagnosis and a close monitoring throughout the treatment implementing nutritional support as needed. Results: From June 2011 until October 2012, 20 patients were included. Nutritional and anthropometric parameters were collected at diagnosis, post iCT, after radiotherapy, 1 and 3 months post radiotherapy. According to Patient Generated Subjective Global Assessment, 30% of patients were malnourished at diagnosis. After iCT there was an increase in weight, body mass index (BMI) and fat free mass (FFM) with almost complete improvement in dysphagia and odynophagia. Nevertheless a significant nutritional deterioration (p = 0.0022) occurred at the end of radiotherapy with 95% of patients becoming severe or moderate malnourished. Nutritional parameters such as weight, BMI and hand grip strength also decrease significantly during treatment. Conclusions: Despite an intensive nutritional support from the diagnosis throughout the oncological treatment in advanced HNSCC cancer patients, nutritional status deteriorates during radiotherapy. Our findings suggest that iCT may help improve nutritional status by ameliorating the symptoms that limit the oral intake. This improvement in the nutritional status could contribute to minimize further deterioration. Further investigations are needed involving novel approaches to avoid nutritional deterioration. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:67 / 74
页数:8
相关论文
共 50 条
  • [1] Chemotherapy in the treatment of locally advanced head and neck cancer
    Forastiere, Arlene A.
    JOURNAL OF SURGICAL ONCOLOGY, 2008, 97 (08) : 701 - 707
  • [2] Improved tolerance and treatment intensity in patients with locally advanced head and neck cancer
    Billard-Sandu, C.
    Blanchard, P.
    Tao, Y. G.
    Nguyen, F.
    Dumitrescu, G.
    Rassy, E.
    Assi, T.
    Zeghondy, J.
    Sun, R.
    Scotte, F.
    Di Palma, M.
    Breuskin, I.
    Temam, S.
    Akla, S.
    Deutsch, E.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S588 - S589
  • [3] Taxotere© (Docetaxel) in the treatment of patients with locally advanced and metastatic head & neck cancer
    Schöffski, P
    Weihkopf, T
    Ganser, A
    BRITISH JOURNAL OF CANCER, 1998, 77 : 38 - 38
  • [4] CT imaging during treatment improves radiomic models for patients with locally advanced head and neck cancer
    Leger, Stefan
    Zwanenburg, Alex
    Pilz, Karoline
    Zschaeck, Sebastian
    Zoephel, Klaus
    Kotzerke, Joerg
    Schreiber, Andreas
    Zips, Daniel
    Krause, Mechthild
    Baumann, Michael
    Troost, Esther G. C.
    Richter, Christian
    Loeck, Steffen
    RADIOTHERAPY AND ONCOLOGY, 2019, 130 : 10 - 17
  • [5] Locally advanced head and neck cancer
    Kies M.S.
    Bennett C.L.
    Vokes E.E.
    Current Treatment Options in Oncology, 2001, 2 (1) : 7 - 13
  • [6] Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer
    Kee H. Wong
    Rafal Panek
    Alex Dunlop
    Dualta Mcquaid
    Angela Riddell
    Liam C. Welsh
    Iain Murray
    Dow-Mu Koh
    Martin O. Leach
    Shreerang A. Bhide
    Christopher M. Nutting
    Wim J. Oyen
    Kevin J. Harrington
    Kate L. Newbold
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 759 - 767
  • [7] Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer
    Wong, Kee H.
    Panek, Rafal
    Dunlop, Alex
    Mcquaid, Dualta
    Riddell, Angela
    Welsh, Liam C.
    Murray, Iain
    Koh, Dow-Mu
    Leach, Martin O.
    Bhide, Shreerang A.
    Nutting, Christopher M.
    Oyen, Wim J.
    Harrington, Kevin J.
    Newbold, Kate L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (05) : 759 - 767
  • [8] Dynamic cfHPV DNA changes during induction chemotherapy as an early indicator of treatment responsiveness for locally advanced head and neck cancer patients
    Cao, Y.
    Kiess, A. P.
    Hwang, M.
    Boudadi, K.
    Saloura, V.
    Mattox, A. K.
    Gramiccioni, E.
    Schmitt, D.
    Swindell, J.
    Starus, A.
    Jones, F. S.
    Quon, H.
    Seiwert, T.
    ANNALS OF ONCOLOGY, 2023, 34 : S562 - S563
  • [9] Integrating head and neck cancer immunotherapy into locally advanced treatment
    Ferris, Robert
    CLINICAL CANCER RESEARCH, 2020, 26 (12) : 22 - 22
  • [10] Cisplatin as a radiosensitizer in the treatment of locally advanced head and neck cancer
    Altundag, O
    Altundag, K
    Morandi, P
    Hanrahan, E
    ORAL ONCOLOGY, 2005, 41 (04) : 435 - 435